PURPOSE: Although the use of kidney allografts from expanded criteria donors (ECD) has increased in recent years, the reported discard rates are also growing. The influence of ECD characteristics on transplant outcomes is still underevaluated. METHODS: This retrospective study investigated the influence of preimplantation biopsy findings and delayed graft function (DGF) on patient and graft survivals and renal function at 36 months in a cohort of 372 ECD kidney transplant recipients. RESULTS: Patient and graft survivals were 91.6 and 68.9 %. The incidence of biopsy-proven acute rejection was 31 %. There were no differences in patient (88.6 vs. 91.1 vs. 94.7 vs. 78.6 %, p = 0.10) or graft (78.1 vs. 72.2 vs. 60.5 vs. 62.6 %, p = 0.14) survivals and renal function (41.7 ± 25.6 vs. 39.9 ± 29.9 vs. 38.1 ± 30.6 vs. 37.4 ± 29.2 mL/min, p = 0.79) comparing ECD kidneys with mild, moderate, and severe histological changes or with no preimplantation biopsy, respectively. However, severe scored transplants had the worst death-censored graft survival (OR 3.1, 95 % CI 1.4-6.9, p = 0.007). No significant differences in patient (86.2 vs. 83.4 %, p = 0.17) or graft (73.7 vs. 65.9 %, p = 0.06) survivals and renal function (38.9 ± 28.6 vs. 39.9 ± 28.4 mL/min, p = 0.72) were observed comparing patients with or without DGF. Multivariable analysis found diabetes history as the only independent risk factor for graft loss (OR 2.1, 95 % CI 1.3-3.3, p = 0.003) or patient death (OR 3.1, 95 % CI 1.5-5.8, p < 0.001). CONCLUSIONS: Within the limitations of sample size and short follow-up time, in this cohort of ECD kidney transplant recipients the severity of histological changes observed in preimplantation biopsies was independently associated with graft loss.
PURPOSE: Although the use of kidney allografts from expanded criteria donors (ECD) has increased in recent years, the reported discard rates are also growing. The influence of ECD characteristics on transplant outcomes is still underevaluated. METHODS: This retrospective study investigated the influence of preimplantation biopsy findings and delayed graft function (DGF) on patient and graft survivals and renal function at 36 months in a cohort of 372 ECD kidney transplant recipients. RESULTS:Patient and graft survivals were 91.6 and 68.9 %. The incidence of biopsy-proven acute rejection was 31 %. There were no differences in patient (88.6 vs. 91.1 vs. 94.7 vs. 78.6 %, p = 0.10) or graft (78.1 vs. 72.2 vs. 60.5 vs. 62.6 %, p = 0.14) survivals and renal function (41.7 ± 25.6 vs. 39.9 ± 29.9 vs. 38.1 ± 30.6 vs. 37.4 ± 29.2 mL/min, p = 0.79) comparing ECD kidneys with mild, moderate, and severe histological changes or with no preimplantation biopsy, respectively. However, severe scored transplants had the worst death-censored graft survival (OR 3.1, 95 % CI 1.4-6.9, p = 0.007). No significant differences in patient (86.2 vs. 83.4 %, p = 0.17) or graft (73.7 vs. 65.9 %, p = 0.06) survivals and renal function (38.9 ± 28.6 vs. 39.9 ± 28.4 mL/min, p = 0.72) were observed comparing patients with or without DGF. Multivariable analysis found diabetes history as the only independent risk factor for graft loss (OR 2.1, 95 % CI 1.3-3.3, p = 0.003) or patientdeath (OR 3.1, 95 % CI 1.5-5.8, p < 0.001). CONCLUSIONS: Within the limitations of sample size and short follow-up time, in this cohort of ECD kidney transplant recipients the severity of histological changes observed in preimplantation biopsies was independently associated with graft loss.
Authors: D Anglicheau; A Loupy; C Lefaucheur; F Pessione; I Létourneau; I Côté; K Gaha; L-H Noël; N Patey; D Droz; F Martinez; J Zuber; D Glotz; E Thervet; C Legendre Journal: Am J Transplant Date: 2008-09-10 Impact factor: 8.086
Authors: S Gagandeep; L Matsuoka; R Mateo; Y W Cho; Y Genyk; L Sher; J Cicciarelli; S Aswad; N Jabbour; R Selby Journal: Am J Transplant Date: 2006-07 Impact factor: 8.086
Authors: A Arnau; E Rodrigo; E Miñambres; J C Ruiz; M A Ballesteros; C Piñera; G Fernandez-Fresnedo; R Palomar; M Arias Journal: Transplant Proc Date: 2012-11 Impact factor: 1.066
Authors: S Martínez-Vaquera; M D Navarro Cabello; M López-Andreu; J M Dueñas Jurado; C Rodelo Haad; R Ortega Salas; A Rodríguez Benot; J P Campos Hernández; J C Robles Arista; P Aljama Journal: Transplant Proc Date: 2013 Impact factor: 1.066
Authors: Friedrich K Port; Jennifer L Bragg-Gresham; Robert A Metzger; Dawn M Dykstra; Brenda W Gillespie; Eric W Young; Francis L Delmonico; James J Wynn; Robert M Merion; Robert A Wolfe; Philip J Held Journal: Transplantation Date: 2002-11-15 Impact factor: 4.939
Authors: Markus Giessing; T Florian Fuller; Frank Friedersdorff; Serdar Deger; Andreas Wille; Hans-Hellmut Neumayer; Danilo Schmidt; Klemens Budde; Lutz Liefeldt Journal: J Am Soc Nephrol Date: 2008-12-10 Impact factor: 10.121
Authors: Camila M Mazeti-Felicio; Heloisa C Caldas; Ida M M Fernandes-Charpiot; Camila Z Dezotti; Maria A S F Baptista; Mario Abbud-Filho Journal: Transplant Direct Date: 2017-06-23